Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Contractors' service and staffing fears after 'another funding cut'

One contractor warned they may be forced to make redundancies and another has said pharmacy’s service delivery will be hampered after yesterday's funding freeze announcement.

Funding for England’s pharmacies will remain at its current level of £2.592 billion for the remainder of the financial year, the Pharmaceutical Services Negotiating Committee (PSNC) announced yesterday (October 22).

From November, contractors will see a reduction of 3p in the single activity fee – from £1.29 to £1.26 – and a category M clawback of £10 million a month until March 2019, the negotiator explained.

While PSNC stressed that the current funding level is “an improvement” on a £33m cut proposed by the government, the Royal Pharmaceutical Society (RPS) said taking inflation into account, the funding is “still effectively a cut”.

“We completely understand what a tough time the community pharmacy sector is going through right now and empathise with pharmacy owners working within a contractual framework that has, in real terms, seen another cut in funding,” RPS CEO Paul Bennett said.

The society’s English pharmacy board chair Sandra Gidley said the funding will “do little to relieve the pressure on pharmacies”.

However, she said she is “pleased that negotiation conversations have now started” and the RPS “looks forward to seeing developments move towards a contract based on services for next year’s settlement”.

“Do I make redundancies?”

Raj Radia, owner of Spring Pharmacy in London, said he is “devastated” that community pharmacies in England will not receive any more money to reflect their increasing workload.

“It’s going to be very hard going forward,” he told C+D. “Cashflow has been a real issue this year. How do you make the two ends meet?”

“The staffing will be affected in some way. Where do I cut? Do I make redundancies? It’s daunting.”

“No surprise”

Mike Hewitson, owner of Beaminster Pharmacy in Dorset, was also unimpressed by the funding announcement, but said it was “not a surprise”.

“The government may have shot itself in the foot, as I can only see it increasing pressure on pharmacies. It’s not going to make it any easier for us to deliver services.”

“We have got massive cost pressures: the Falsified Medicines Directive (FMD), living wage, rise of medicines costs, among others – all piling up and no recognition of that,” he added.

“It’s important contractors have faith in the checks and balances in the system so we can be confident it equates to fair delivery of funding.”

NPA: “Cat M most pressing concern”

The National Pharmacy Association (NPA) said while it understood “why PSNC has accepted the Department of Health and Social Care (DH)’s offer”, the agreement will be a “disappointment to many of our members”.

“[PSNC’s] rationale is in part to demonstrate a desire to develop constructive relationships with government, as the basis for positive developments in pharmacy policy and commissioning,” it said.

However, the “most immediate concern is the impact of the category M clawback, which could impair cashflow”.

The sector needs a “long-term settlement” that has more certainty, as well as “clarity from the government about their ambitions for the sector”, the NPA added.

Well: “A significant challenge”

Well Pharmacy also emphasised the importance of the government’s relationship with the sector, and said rebuilding this must be the priority, with the “aim of providing certainty for contractors”.

“The financial climate in community pharmacy continues to pose a significant challenge to contractors,” CEO John Nuttall said.

“The ongoing challenge of category M clawback leads to instability and uncertainty in the market, and needs to be addressed by a new funding model,” Mr Nuttall stressed.

CCA “pleased” there are no more cuts

The Company Chemists’ Association – which represents Boots, Lloydspharmacy, Well, Rowlands and Superdrug, as well as the pharmacy arms of Morrisons, Tesco and Asda – said it is “pleased that there will be no further cuts”, but “does not underestimate the financial challenges that all contractors currently face”.

“Our members look forward to working with government in the coming months and years to help design and evolve the pharmacy contract to deliver the best possible service for patients and the public,” said chief executive Malcolm Harrison. 

Twitter reaction

Read C+D editor James Waldron's thoughts on the funding announcement here.

Have funding cuts affected your pharmacy in the last 12 months? Is the picture different in Scotland, Northern Ireland and Wales? Take the C+D Salary Survey and tell us how community pharmacy across the UK is faring – complete the survey here

C+D Salary Survey banner

How will your pharmacy cope with the ongoing funding pressures?

Related Content


Pharmacy Manager / Pharmacist

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts